合計 50 件の最近のインサイダー取引記録が記録されています Alpine Immune Sciences, Inc. (ALPN), 内訳は 13 件の買い および 37 件の売り. インサイダー買い総額は $2.7M インサイダー売り総額は $559.86M.
最近活動のある主要インサイダーには Conway Robert E, Gold Mitchell, Topper James N. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — ALPN
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2024-05-20 |
Conway Robert E |
Director |
株式返還 |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Gold Mitchell |
Executive Chairman and CEO |
株式返還 |
240,000 |
$18.33 |
$4.4M |
- |
| 2024-05-20 |
Topper James N |
Director |
株式返還 |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Thompson Peter A. |
Director |
株式返還 |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Cui Xiangmin |
10 Percent Owner |
株式返還 |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Rickey James Paul |
See Remarks |
株式返還 |
78,000 |
$18.33 |
$1.43M |
- |
| 2024-05-20 |
Peetz Christopher |
Director |
株式返還 |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Peng Stanford L |
See Remarks |
株式返還 |
120,000 |
$18.33 |
$2.2M |
- |
| 2024-05-20 |
Hernday Natasha |
Director |
株式返還 |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Drappa Jorn |
Director |
株式返還 |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Durand Remy |
Chief Business Officer |
株式返還 |
78,000 |
$18.33 |
$1.43M |
- |
| 2024-05-20 |
Fuhs Ulrich Martin |
Chief Accounting Officer |
株式返還 |
14,600 |
$35.89 |
$523.99K |
- |
| 2024-05-18 |
Orbimed Advisors Llc |
Director |
TOB（売り） |
264,315 |
$65.00 |
$17.18M |
- |
| 2024-05-18 |
Gold Mitchell |
Executive Chairman and CEO |
TOB（売り） |
2,627,157 |
$65.00 |
$170.77M |
- |
| 2024-05-18 |
Topper James N |
Director |
TOB（売り） |
2,829,347 |
$65.00 |
$183.91M |
- |
| 2024-05-18 |
Thompson Peter A. |
Director |
TOB（売り） |
264,315 |
$65.00 |
$17.18M |
- |
| 2024-05-18 |
Cui Xiangmin |
10 Percent Owner |
TOB（売り） |
1,735,544 |
$65.00 |
$112.81M |
- |
| 2024-05-08 |
Gold Mitchell |
Executive Chairman and CEO |
オプション行使 |
13,245 |
$7.55 |
$100K |
109,245 |
| 2024-05-08 |
Peng Stanford L |
See Remarks |
オプション行使（売却） |
161,492 |
$0.65 |
$104.97K |
- |
| 2024-05-08 |
Durand Remy |
Chief Business Officer |
オプション行使（売却） |
10,000 |
$4.76 |
$47.6K |
- |
| 2024-05-08 |
Fuhs Ulrich Martin |
Chief Accounting Officer |
オプション行使 |
22,820 |
$12.07 |
$275.44K |
30,120 |
| 2024-05-07 |
Rickey James Paul |
See Remarks |
オプション行使（売却） |
398 |
$5.02 |
$2K |
137 |
| 2024-04-25 |
Topper James N |
Director |
オプション行使（ITM） |
1,200,000 |
$0.00 |
$1.2K |
- |
| 2024-04-03 |
Fuhs Ulrich Martin |
Chief Accounting Officer |
処分 |
14,600 |
$35.89 |
$523.99K |
- |
| 2024-01-26 |
Rickey James Paul |
See Remarks |
情報に基づく売り |
73,764 |
$22.31 |
$1.65M |
- |
| 2024-01-25 |
Rickey James Paul |
See Remarks |
情報に基づく売り |
236 |
$22.00 |
$5.19K |
- |
| 2024-01-18 |
Cui Xiangmin |
10 Percent Owner |
オプション行使（ITM） |
1,234,636 |
$12.74 |
$15.73M |
- |
| 2024-01-18 |
Decheng Capital China Life Sciences Usd Fund Iii, L.p. |
10 Percent Owner |
オプション行使（ITM） |
1,234,636 |
$12.74 |
$15.73M |
- |
| 2024-01-11 |
Orbimed Advisors Llc |
Director |
オプション行使（ITM） |
145,251 |
$12.74 |
$1.85M |
- |
| 2024-01-11 |
Thompson Peter A. |
Director |
オプション行使（ITM） |
145,251 |
$12.74 |
$1.85M |
- |
| 2024-01-04 |
Gold Mitchell |
Executive Chairman and CEO |
RSU 付与（制限付株式） |
96,000 |
- |
- |
96,000 |
| 2024-01-04 |
Rickey James Paul |
See Remarks |
RSU 付与（制限付株式） |
31,200 |
- |
- |
31,200 |
| 2024-01-04 |
Peng Stanford L |
See Remarks |
RSU 付与（制限付株式） |
48,000 |
- |
- |
72,371 |
| 2024-01-04 |
Durand Remy |
Chief Business Officer |
RSU 付与（制限付株式） |
31,200 |
- |
- |
38,104 |
| 2024-01-02 |
Conway Robert E |
Director |
RSU 付与（制限付株式） |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Topper James N |
Director |
RSU 付与（制限付株式） |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Thompson Peter A. |
Director |
RSU 付与（制限付株式） |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Cui Xiangmin |
10 Percent Owner |
RSU 付与（制限付株式） |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Peetz Christopher |
Director |
RSU 付与（制限付株式） |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Hernday Natasha |
Director |
RSU 付与（制限付株式） |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Drappa Jorn |
Director |
RSU 付与（制限付株式） |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2023-12-28 |
Orbimed Advisors Llc |
Director |
情報に基づく売り |
139,166 |
$18.32 |
$2.55M |
264,315 |
| 2023-12-28 |
Gold Mitchell |
Executive Chairman and CEO |
オプション行使（売却） |
74,441 |
$12.74 |
$948.38K |
- |
| 2023-12-28 |
Thompson Peter A. |
Director |
情報に基づく売り |
139,166 |
$18.32 |
$2.55M |
264,315 |
| 2023-12-27 |
Gold Mitchell |
Executive Chairman and CEO |
情報に基づく売り |
29,573 |
$20.04 |
$592.72K |
- |
| 2023-12-27 |
Orbimed Advisors Llc |
Director |
情報に基づく売り |
18,922 |
$19.96 |
$377.68K |
406,609 |
| 2023-12-27 |
Thompson Peter A. |
Director |
情報に基づく売り |
18,922 |
$19.96 |
$377.68K |
406,609 |
| 2023-12-26 |
Gold Mitchell |
Executive Chairman and CEO |
オプション行使（売却） |
2,402 |
$0.45 |
$1.08K |
- |
| 2023-12-22 |
Gold Mitchell |
Executive Chairman and CEO |
情報に基づく売り |
37,825 |
$20.43 |
$772.59K |
- |
| 2023-12-19 |
Gold Mitchell |
Executive Chairman and CEO |
情報に基づく売り |
2,402 |
$20.01 |
$48.06K |
- |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
